SCHEMBL23488494

SCHEMBL23488494

COc1cc(C(=O)O[C@H]2[C@@H](OC)O[C@H](CO)[C@@H](O)[C@@H]2O)ccc1OCc1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.50
RAB9A P51151 2/20 0.50
HPGD P15428 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
LGALS8 O00214 4/20 0.49
LGALS3 P17931 6/20 0.45
LGALS4 P56470 2/20 0.45
LGALS9 O00182 3/20 0.45
LGALS1 P09382 3/20 0.45
LGALS7; LGALS7B P47929 3/20 0.45
KDM4E B2RXH2 1/20 0.45
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
SMPD1 P17405 1/20 0.44
HDAC1 Q13547 1/20 0.44
HDAC8 Q9BY41 1/20 0.44
HDAC6 Q9UBN7 1/20 0.44
ACHE P22303 1/20 0.44
MRGPRX4 Q96LA9 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23488437 0.91 LGALS3 (0.44) LGALS8LGALS3LGALS4LGALS9LGALS1
SCHEMBL23488497 0.90 LGALS8 (0.48) NPC1RAB9AHPGDSMN1; SMN2LGALS8
SCHEMBL23488620 0.87 LGALS3 (0.49) LGALS8LGALS3LGALS4LGALS9LGALS1
SCHEMBL21112948 0.87 TTR (0.49) LGALS8LGALS3LGALS4LGALS9LGALS1
SCHEMBL23488697 0.86 LGALS8 (0.47) LGALS8LGALS3LGALS4LGALS9LGALS1
SCHEMBL23488707 0.86 LGALS8 (0.47) SMN1; SMN2LGALS8LGALS3LGALS4LGALS9
SCHEMBL23488610 0.86 LGALS8 (0.47) SMN1; SMN2LGALS8LGALS3LGALS4LGALS9
SCHEMBL23488417 0.85 LGALS8 (0.53) LGALS8LGALS3LGALS4LGALS9LGALS1
SCHEMBL23488143 0.85 LGALS8 (0.53) LGALS8LGALS3LGALS4LGALS9LGALS1
SCHEMBL23488412 0.85 LGALS8 (0.53) LGALS8LGALS3LGALS4LGALS9LGALS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210170033-A1 NOVEL CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN SANOFI (FR) 2021-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210170033-A1 NOVEL CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN GPR119, SLC2A8, SLC2A4 NPC1 1840/4885RAB9A 1043/4885HPGD 4318/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.